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adulthood, the growth curve of BMI and BP for each individual were
constructed using a mixed-effects model by SAS PROC MIXED within
both childhood and adulthood. The area under the growth curve
(AUC) was calculated by using an integral calculus formula to char-
acterize the overall BMI and BP levels throughout childhood and
adulthood.
RESULTS The tracking coefﬁcient between childhood AUC and adult
AUC of BMI (r ¼0.635, P <0.001) was greater than between initial
childhood level and last adult level of BMI(r ¼0.575, P <0.001). After
adjusting sex and age at ﬁnal adulthood, BMI at initial childhood, at
ﬁnal childhood, as childhood AUC, and as adult AUC were all associ-
ated with high cfPWV, high cIMT, and high LVMI at adulthood. After
additionally controlling for covariates, four BMI measures still
signiﬁcantly related with high cIMT and high LVMI, but not with high
cfPWV at adulthood. Both BMI measured at ﬁnal adulthood and
adulthood AUC were predictive of adult high cIMT and high LVMI,
whereas neither BMI measured at ﬁnial childhood nor as childhood
AUC was associated with adult high cIMT and high LVMI. Subjects
who were overweight in adulthood, irrespective of their childhood
adiposity status, had signiﬁcantly increased risks of high cIMT and
high LVMI.
CONCLUSIONS Childhood adiposity is associated with carotid
atherosclerosis and left ventricular hypertrophy at adulthood but not
with arterial stiffness. However, reduction in weight from childhood
to adulthood could attenuate and even eliminate the risk of subclin-
ical CVD at adulthood.GW26-e0404
Optimal blood pressure in patients after stroke in rural areas of China
Miaomiao Zhao, Jie Zhang, Jue Li
Heart, Lung and Blood Vessel Center, Tongji University School of
Medicine, Shanghai, China
OBJECTIVES To our knowledge, no publication has estimated the
association between average follow-up blood pressure (BP) and the
risk of developing adverse events and / or mortality among stroke
survivors in rural areas of China. The purpose of this study was to
investigate the impact of different BP categories on risk of developing
worse outcomes and evaluate the target range of BP in patients after
stroke in rural areas of China.
METHODS We performed a post-hoc analysis of 1058 patients with a
history of stroke or transient ischemic attack (TIA) from the NCRCHS.
The average follow-up systolic blood pressure (SBP) and diastolic
blood pressure (DBP) were categorized into 10 mm Hg increments. The
primary outcome was a composite of death due to any cause, nonfatal
coronary heart disease (CHD) and nonfatal stroke. The secondary
outcomes were recurrent stroke, CVD events, CVD mortality, and all-
cause mortality, considered separately.
RESULTS The relationship between BP (systolic and diastolic) fol-
lowed a J- or U-shaped curve with primary and secondary outcomes,
with increased event rates at low and high BP values, both unadjusted
and after adjustment for baseline confounding variables. The event
rates were lowest in SBP of 110-119 mm Hg and DBP of 80-89 mm Hg.
After adjusting for baseline covariates, compared with the reference
group (SBP 110-119 mm Hg), SBP<110 mm Hg and SBP150 mm Hg
were signiﬁcantly associated with an increased risk of primary
outcome. For the secondary outcomes, SBP140 mm Hg was associ-
ated with an increased risk of recurrent stroke and SBP160 mm Hg
was associated with an increased risk of total CVD events. Both
SBP<110 mm Hg and SBP170 mm Hg signiﬁcantly increased the risk
of CVD and all-cause mortality. For DBP, compared with the reference
group (DBP 80-89 mm Hg), patients with DBP<70 mm Hg or
DBP90 mm Hg had a signiﬁcantly increased risk of primary outcome.
For the secondary outcomes, DBP90 mm Hg signiﬁcantly increased
the risk of both recurrent stroke and total CVD events. DBP<70 mm Hg
and DBP100 mm Hg were independently associated with an
increased risk of CVD mortality. DBP<70 mm Hg and DBP90 mm Hg
were independently associated with an increased risk of all-cause
mortality. Patients with SBP<110 mm Hg or SBP140 mm Hg /
DBP<70 mm Hg or DBP90 mm Hg had signiﬁcantly and indepen-
dently increased risk of worse outcomes.
CONCLUSIONS For stroke survivors, a J- or U-shaped curve associa-
tion exists between BP and the risk of future CVD events and mor-
tality, with lowest event rates in the BP range of 110-119 mm Hg
systolic and 80-89 mm Hg diastolic. SBP of 110-139 mm Hg and DBP of
70-89 mm Hg are the appropriate range for patients after stroke in
rural areas of China.GW26-e0701
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OBJECTIVES A positive family history of hypertension is a risk factor
for cardiovascular diseases. In the present study, we investigated the
value of pulse wave velocity (PWV) in healthy subjects with a positive
family history of hypertension.
METHODS 255 healthy subjects (M/F: 75/180) were divided into two
groups according to without (group 1) or with (group 2) a positive
family history of hypertension. Carotid-femoral pulse wave velocity
(CF-PWV) was measured by Complior apparatus.
RESULTS Our results showed that CF-PWV was signiﬁcantly higher in
group 2 than in group 1 (9.871.64 vs 9.161.44 m/s, p<0.001). The
levels of systolic blood pressure (SBP), pulse pressure and mean blood
pressure (MAP) were signiﬁcantly higher in group 1 than in group 2 (all
p<0.05). High-density lipoprotein cholesterol (HDL-C) was signiﬁcant
higher in group 1 than in group 2 (1.630.41 vs 1.400.38 mmol/L,
p¼0.006). CF-PWV was negatively correlated with HDL-C (r¼ -0.142,
p¼0.026) even after adjusting for SBP and pulse pressure (r¼ -0.137,
p¼0.033). Multiple linear regressions showed that age, family history,
GLU and MAP were independent inﬂuencing factors of CF-PWV in the
entire study group.
CONCLUSIONS Our present study showed PWV is signiﬁcantly higher
in healthy subjects with a positive family history of hypertension.
Family history might play an important role in this process. However,
to be able to evaluate the prognostic value of PWV, prospective
studies in families with hypertension are needed.
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Metabolically Healthy Obesity and left ventricular hypertrophy
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OBJECTIVES Obesity is often accompanied by metabolic abnormal-
ities, and both of them are risk factors for cardiovascular diseases.
However, a subgroup of obesity which is not accompanied by meta-
bolic abnormalities, also known as metabolically health obesity
(MHO), appears to be a lower risk for cardiovascular diseases. As far as
we know, no studies verify whether MHO is associated with LVH up to
now. Therefore, this cross-sectional study is to investigate whether
MHO is signiﬁcantly associated with LVH ﬁrst and then clarify which
obesity phenotypes and metabolic abnormalities work in association
with LVH
METHODS This population-based cross-sectional study of 10,804
participants in rural Liaoning Province during 2012–2013. Obesity and
metabolically healthy were deﬁned as BMI28 kg/m2 and not having
the metabolic syndrome, respectively. left ventricular hypertrophy
(LVH) was deﬁned as left ventricular mass index (LVMI) > 125 g/m2 in
men and > 110 g/m2 in women
RESULTS There were 10,804 participants evaluated in this cross-
sectional study and the prevalence of MHNO, MUNO, MHO and MUO
was 38.1% (n¼4119), 44.3% (n¼4783), 3.7% (n¼398) and 13.9%
(n¼1504), respectively. The total prevalence of LVH was 5.6% and
6.8% in MUNO, 9.0% in MUO, 3.2% in MHNO, 4.3% in MHO. In addi-
tion, the prevalence of LVH was signiﬁcant increased in high blood
pressure (7.6%), high WC (7.5%), high glucose level (6.5%), low HDL
cholesterol (6.6%) and high triglycerides (7.2%). The relationships of
MUO (OR, 2.882; 95%CI, 2.235-3.715, P < 0.001) and MUNO (OR, 1,733;
95%CI, 1.401-2.143, P < 0.001), but not MHO (OR, 1,575; 95%CI, 0.933-
2.659, P ¼ 0.089) and MHNO (reference), being associated with LVH.
In addition, Among the ﬁve metabolic components used in the deﬁ-
nition of MetS, high blood pressure (OR, 3.695; 95%CI, 2.732-4.996,
P < 0.001) and high WC (OR, 1.515; 95%CI, 1.254-1.831, P < 0.001) were
signiﬁcant associated with LVH. However, high fasting glucose (OR,
0.975; 95%CI, 0.819-1.159, P ¼ 0.772), low HDL cholesterol (OR, 1.183;
95%CI, 0.974-1.435, P ¼ 0.090) and high triglycerides (OR, 1.114; 95%
CI, 0.926-1.341, P ¼ 0.252) were not associated with LVH.
CONCLUSIONS The main ﬁnding of our study was that with all known
risk factors for LVH adjusted, MHO is excluded from, while MUNO and
MUO are included in independent risk factors for LHV. More specif-
ically, among metabolic abnormalities, high blood pressure and WC
are found to be two major independent risk factors for LVH.
